Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Common stock and Paid-In Capital	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2023	$ 539,106		$ 1,191,831	$ 977	$ (653,702)
Beginning Balance, Shares at Dec. 31, 2023		68,175,000
Issuance of common stock, net of transaction costs, shares		9,557,000
Issuance of common stock, net of transaction costs, value	378,890		378,890
Issuance of common stock upon vesting of restricted stock units shares		202,000
Exercise of stock options	11,240		11,240
Exercise of stock options, shares		605,000
Stock-based compensation	13,454		13,454
Other comprehensive income	(827)			(827)
Net Income (Loss)	(66,930)				(66,930)
Ending Balance at Mar. 31, 2024	874,933		1,595,415	150	(720,632)
Ending Balance, Shares at Mar. 31, 2024		78,539,000
Beginning Balance at Dec. 31, 2024	1,324,805		2,275,952	963	(952,110)
Beginning Balance, Shares at Dec. 31, 2024		92,926,000
Issuance of common stock upon vesting of restricted stock units shares		384,000
Exercise of stock options	$ 4,452		4,452
Exercise of stock options, shares	215,439	215,000
Stock-based compensation	$ 20,478		20,478
Other comprehensive income	1,039			1,039
Net Income (Loss)	(96,774)				(96,774)
Ending Balance at Mar. 31, 2025	$ 1,254,000		$ 2,300,882	$ 2,002	$ (1,048,884)
Ending Balance, Shares at Mar. 31, 2025		93,525,000